Literature DB >> 12665525

JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells.

Dharminder Chauhan1, Guilan Li, Teru Hideshima, Klaus Podar, Constantine Mitsiades, Nicholas Mitsiades, Nikhil Munshi, Surender Kharbanda, Kenneth C Anderson.   

Abstract

Smac, second mitochondria-derived activator of caspases, promotes apoptosis via activation of caspases. Previous studies have shown that c-Jun NH(2)-terminal kinase (JNK) is involved in regulating another mitochondrial protein, cytochrome c during apoptosis; however, the role of JNK in the release of mitochondrial Smac is unknown. Here we show that induction of apoptosis in multiple myeloma (MM) cells is associated with activation of JNK, translocation of JNK from cytosol to mitochondria, and release of Smac from mitochondria to cytosol. Blocking JNK either by dominant-negative mutant (DN-JNK) or cotreatment with a specific JNK inhibitor, SP600125, abrogates both stress-induced release of Smac and induction of apoptosis. These findings demonstrate that activation of JNK is an obligatory event for the release of Smac during stress-induced apoptosis in MM cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665525     DOI: 10.1074/jbc.C300076200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

Review 2.  Mitochondrial function in apoptotic neuronal cell death.

Authors:  Samantha L Budd Haeberlein
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 3.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

Review 4.  Mitochondrial signaling pathways: a receiver/integrator organelle.

Authors:  Michael J Goldenthal; José Marín-García
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

5.  Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.

Authors:  Merav Leiba; Jana Jakubikova; Steffen Klippel; Constantine S Mitsiades; Teru Hideshima; Yu-Tzu Tai; Adi Leiba; Mark Pines; Paul G Richardson; Arnon Nagler; Kenneth C Anderson
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

6.  The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.

Authors:  Simona Colla; Fenghuang Zhan; Wei Xiong; Xiaosong Wu; Hongwei Xu; Owen Stephens; Shmuel Yaccoby; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

Review 7.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

Review 8.  Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Ye Shen; Taylor J Chen; H Daniel Lacorazza
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

9.  A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis.

Authors:  Avijit Paul; Yakov Krelin; Tasleem Arif; Rina Jeger; Varda Shoshan-Barmatz
Journal:  Mol Ther       Date:  2017-12-24       Impact factor: 11.454

10.  Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition.

Authors:  Andrea Rasola; Marco Sciacovelli; Federica Chiara; Boris Pantic; William S Brusilow; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.